Experimental Evidence for Anti-metastatic Actions of Apigenin: a Mini Review

Overview

Journal Front Oncol

Specialty Oncology

Date 2024 Mar 22

PMID 38515580

Authors

Hyeon-Muk Oh

Chong-Kwan Cho

Nam-Hun Lee

Chang-Gue Son

Affiliations

Soon will be listed here.

Abstract

Cancer metastasis is responsible for the majority of cancer-related deaths. Accordingly, to reduce metastasis remains a vital challenge in clinical practice, and phytochemicals have taken an attention as anti-metastatic agents. Apigenin, a plant flavone, showed anti-cancer effects against in various animal models, moreover its potentials inhibiting tumor metastasis have been reported. Herein, we analyzed the overall features at what apigenin inhibited metastasis and its action modes. We searched for articles in MEDLINE (Pubmed), EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) through March 2023. Total 6 animal studies presented anti-metastatic effects of apigenin using 5 difference experimental models, while the mechanisms involved modulations of epithelial-mesenchymal transition (EMT), matrix metalloproteinases (MMPs), angiogenesis, and various metastasis-related signaling pathways. This review provides an overall potential of apigenin as a candidate reducing the risk of cancer metastasis.

References

Power Coombs M, Harrison M, Hoskin D . Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells. Cancer Lett. 2016; 380(2):424-433. DOI: 10.1016/j.canlet.2016.06.023. View

Ross J, Kasum C . Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002; 22:19-34. DOI: 10.1146/annurev.nutr.22.111401.144957. View

Nozhat Z, Heydarzadeh S, Memariani Z, Ahmadi A . Chemoprotective and chemosensitizing effects of apigenin on cancer therapy. Cancer Cell Int. 2021; 21(1):574. PMC: 8555304. DOI: 10.1186/s12935-021-02282-3. View

Szender J, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K . Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study. Gynecol Oncol. 2017; 146(3):491-497. PMC: 5568462. DOI: 10.1016/j.ygyno.2017.06.008. View

Yang J, Pi C, Wang G . Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed Pharmacother. 2018; 103:699-707. DOI: 10.1016/j.biopha.2018.04.072. View

Liu L, Fang J, Zhou Q, Hu X, Shi X, Jiang B . Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol Pharmacol. 2005; 68(3):635-43. DOI: 10.1124/mol.105.011254. View

Yan X, Qi M, Li P, Zhan Y, Shao H . Apigenin in cancer therapy: anti-cancer effects and mechanisms of action. Cell Biosci. 2017; 7:50. PMC: 5629766. DOI: 10.1186/s13578-017-0179-x. View

Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L . Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One. 2012; 6(12):e29169. PMC: 3244456. DOI: 10.1371/journal.pone.0029169. View

Sandru A, Voinea S, Panaitescu E, Blidaru A . Survival rates of patients with metastatic malignant melanoma. J Med Life. 2015; 7(4):572-6. PMC: 4316142. View

10.

Tatsuta A, Iishi H, Baba M, Yano H, Murata K, Mukai M . Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis. 2002; 18(8):657-62. DOI: 10.1023/a:1013133803806. View

11.

Lin Y, Lee L, Lee W, Chu C, Tan P, Yang Y . Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. J Pineal Res. 2016; 60(3):277-90. DOI: 10.1111/jpi.12308. View

12.

Rahmani A, Alsahli M, Almatroudi A, Almogbel M, Khan A, Anwar S . The Potential Role of Apigenin in Cancer Prevention and Treatment. Molecules. 2022; 27(18). PMC: 9505045. DOI: 10.3390/molecules27186051. View

13.

Osada M, Imaoka S, Funae Y . Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett. 2004; 575(1-3):59-63. DOI: 10.1016/j.febslet.2004.08.036. View

14.

Cao H, Chu J, Kwan H, Su T, Yu H, Cheng C . Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci Rep. 2016; 6:21731. PMC: 4766576. DOI: 10.1038/srep21731. View

15.

He J, Xu Q, Wang M, Li C, Qian X, Shi Z . Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model. Int J Mol Sci. 2012; 13(6):7271-7282. PMC: 3397525. DOI: 10.3390/ijms13067271. View

16.

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

17.

Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E . Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997; 146(3):223-30. DOI: 10.1093/oxfordjournals.aje.a009257. View

18.

Hoensch H, Groh B, Edler L, Kirch W . Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J Gastroenterol. 2008; 14(14):2187-93. PMC: 2703843. DOI: 10.3748/wjg.14.2187. View

19.

Samatov T, Tonevitsky A, Schumacher U . Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer. 2013; 12(1):107. PMC: 3848796. DOI: 10.1186/1476-4598-12-107. View

20.

Kciuk M, Gielecinska A, Budzinska A, Mojzych M, Kontek R . Metastasis and MAPK Pathways. Int J Mol Sci. 2022; 23(7). PMC: 8998814. DOI: 10.3390/ijms23073847. View